Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Is Restricting This Johnson & Johnson Drug
Wall St. Cheat Sheet
Monday, July 29, 2013 - 10:36am
tags:
antifungals, FDA, JNJ, Nizoral
Court’s decision in MS drug patent dispute spells trouble for Teva
MedCity News
Sunday, July 28, 2013 - 11:21am
tags:
Teva, generics, Copaxone
InterMune Successfully Entering Huge Niche Market Unchallenged
Seeking Alpha
Sunday, July 28, 2013 - 11:18am
tags:
InterMune, Esbriet, idiopathic pulmonary fibrosis
Amgen Keeps Dividend Steady
Motley Fool
Sunday, July 28, 2013 - 11:16am
tags:
Amgen
China Biotech In Review: Despite Its China Problems, GlaxoSmithKline Moving Forward With Vaccine Collaboration Plan
Seeking Alpha
Sunday, July 28, 2013 - 11:15am
tags:
GSK, Zhejiang Hisun Pharma, Celsion, Lumenis, BGI Shenzhen
This Week in Biotech
Motley Fool
Sunday, July 28, 2013 - 11:13am
tags:
Array Biopharma, Biocryst, Forrest, Vertex Pharmaceuticals, Teva
Sequenom's 30% Nosedive Leads an Up-and-Down Week in Biotech
Motley Fool
Sunday, July 28, 2013 - 11:12am
tags:
Sequenom
Takeda unblinds ELM-PC 5 phase III study of orteronel in patients with mCRPC
Pharmabiz
Saturday, July 27, 2013 - 11:45am
tags:
Takeda, ELM-PC, prostate cancer
Court overturns patents on Teva's MS drug Copaxone
BusinessWeek
Saturday, July 27, 2013 - 11:27am
tags:
Teva, lawsuits, generics, Copaxone, Mylan, Momenta
BioMarin Provides BMN 673 Program Update
Virtual Strategy
Saturday, July 27, 2013 - 11:25am
tags:
Biomarin, BMN 673, breast cancer
[vid] Better Dividend: Pfizer vs. Bristol-Myers Squibb
Motley Fool
Saturday, July 27, 2013 - 11:22am
tags:
Pfizer, Bristol-Myers Squibb
3 Things You Need to Know From AbbVie's Q2 Earnings
Motley Fool
Saturday, July 27, 2013 - 11:20am
tags:
earnings
Why We Think Neurocrine's Phase IIb Trial Of NBI-98854 Will Be A Success
Seeking Alpha
Saturday, July 27, 2013 - 11:19am
tags:
Neurocrine Biosciences, NBI-98854, tardive dyskinesia
Earnings Beat at Alkermes
Yahoo/Zacks
Saturday, July 27, 2013 - 11:18am
tags:
Alkermes, earnings
Merck Profit Expected to Fall
Forbes
Saturday, July 27, 2013 - 11:17am
tags:
Merck, earnings
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, July 27, 2013 - 11:16am
tags:
Array Biopharma, Prosensa, InterMune
Onconova's Public Debut: What You'll Want To Know
Seeking Alpha
Saturday, July 27, 2013 - 11:15am
tags:
Onconova, IPOs
Merrimack Progresses with MM-111
Yahoo/Zacks
Saturday, July 27, 2013 - 11:13am
tags:
Merrimack Pharmaceuticals, cancer, gastric cancer, esophageal cancer, gastroesophageal cancer
Amgen Announces 2013 Third Quarter Dividend
Yahoo/PR Newswire
Saturday, July 27, 2013 - 11:11am
tags:
Amgen
Theravance Narrows Loss
Yahoo/Zacks
Saturday, July 27, 2013 - 11:10am
tags:
Theravance, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.